THE HEPATOTOXICITY OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (CCNU) IN RATS - ULTRASTRUCTURAL EVIDENCE OF A DELAYED MICROTUBULAR TOXICITY

被引：0

作者：

DUCASTELLE, T

RAGUENEZVIOTTE, G

FOUINFORTUNET, H

MATYSIAK, M

HEMET, J

FILLASTRE, JP

机构：

[1] UNIV ROUEN,INSERM,U295,UER MED PHARM,ROUEN,FRANCE

[2] UNIV ROUEN,UER MED PHARM,BIOCHIM & PHYSIOPATHOL DIGEST & NUTR GRP,ROUEN,FRANCE

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1988年 / 22卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：153 / 162

页数：10

共 50 条

[41] BINDING OF C-14-LABELED 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (CCNU) TO MACROMOLECULES OF SENSITIVE AND RESISTANT TUMORS
CONNORS, TA
HARE, JR
BRITISH JOURNAL OF CANCER, 1974, 30 (05) : 477 - 480
[42] IDENTIFICATION OF CARBAMOYLATED THIOL CONJUGATES AS METABOLITES OF THE ANTINEOPLASTIC 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA, IN RATS AND HUMANS
BOREL, AG
ABBOTT, FS
DRUG METABOLISM AND DISPOSITION, 1993, 21 (05) : 889 - 901
[43] EFFECT OF PHOSPHOLIPIDS ON MAINTENANCE OF CYTOTOXICITY OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA IN AQUEOUS SUSPENSION
MAKER, HS
SYED, HH
LEHRER, GM
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 60 (05) : 1055 - 1057
[44] ABSORPTION, DISTRIBUTION, EXCRETION, AND BIOTRANSFORMATION OF CARCINOSTATIC 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA IN ANIMALS
OLIVERIO, VT
VIETZKE, WM
WILLIAMS, MK
ADAMSON, RH
CANCER RESEARCH, 1970, 30 (05) : 1330 - &
[45] MODIFICATION OF PROTEINS BY 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (NSC 79037) IN-VITRO
SCHMALL, B
CHENG, CJ
FUJIMURA, S
GERSTEN, N
GRUNBERG.D
WEINSTEI.IB
CANCER RESEARCH, 1973, 33 (08) : 1921 - 1924
[46] UPTAKE, DISTRIBUTION, AND ANTITUMOR ACTIVITY OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA IN MURINE GLIOMA
LEVIN, VA
SHAPIRO, WR
CLANCY, TP
OLIVERIO, VT
CANCER RESEARCH, 1970, 30 (10) : 2451 - +
[47] POTENTIATION OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA BY AMPHOTERICIN-B IN MURINE EPENDYMOBLASTOMA
LAURENT, G
ATASSI, G
HILDEBRAND, J
CANCER RESEARCH, 1976, 36 (11) : 4069 - 4073
[48] THERAPY OF HODGKINS-DISEASE - CCNU, 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA, AND BCNU, 1 3-BIS-(2-CHLOROETHYL)-1-NITROSOUREA) AND BCNU COMBINATIONS IN LYMPHOGRANULOMA, STAGE III AND IV
BRUNNER, KW
MAURICE, P
SONNTAG, RW
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 102 (43) : 1546 - &
[49] THE EFFECTS OF BCNU (1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA) AND CCNU (1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA) ON GLUTATHIONE-REDUCTASE AND OTHER ENZYMES IN MOUSE-TISSUE
MAKER, HS
WEISS, C
BRANNAN, TS
RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1983, 40 (03): : 355 - 366
[50] Induction of specific-locus and dominant lethal mutations in male mice by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)
Ehling, UH
Adler, ID
Favor, J
NeuhauserKlaus, A
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 379 (02) : 219 - 231

← 1 2 3 4 5 →